New study shows intermittent HT as effective as continuous HT
Options
vartabebo
Member Posts: 10
This report was apparently published today at the annual meeting of the American Society of Clinical Oncology...
http://www.medicalnewstoday.com/releases/227668.php
http://www.medicalnewstoday.com/releases/227668.php
0
Comments
-
NCCN may alter their guidelines
Arthur
Great news. These findings will influence the importance given to the newer drugs as well (such as Abiraterone acetate), which do not make part of the protocols of the patients/cases used in the trials but have proven effectiveness with lesser side effects.
I hope institutions like NCCN will alter their guidelines and introduce newer measures regarding HT, based on truthful results like these.
Here is the abstract of the trials;
http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=102&abstractID=77775
Thanks for posting the article.
VG0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.2K Cancer specific
- 2.8K Anal Cancer
- 440 Bladder Cancer
- 306 Bone Cancers
- 1.6K Brain Cancer
- 28.4K Breast Cancer
- 391 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 12.9K Head and Neck Cancer
- 6.3K Kidney Cancer
- 666 Leukemia
- 789 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 235 Multiple Myeloma
- 7.1K Ovarian Cancer
- 53 Pancreatic Cancer
- 486 Peritoneal Cancer
- 5.3K Prostate Cancer
- 1.2K Rare and Other Cancers
- 532 Sarcoma
- 717 Skin Cancer
- 647 Stomach Cancer
- 190 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards